Sarit Samira

Title: Sarit Samira: Innovator in Hepatitis B Virus Vaccination

Introduction

Sarit Samira is a notable inventor based in Raanana, Israel. She has made significant contributions to the field of immunology, particularly in the development of vaccines against Hepatitis B Virus (HBV). Her innovative work has the potential to enhance immune responses and protect individuals from this viral infection.

Latest Patents

Sarit Samira holds a patent for "Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination." This invention focuses on the use of sphingoid-polyalkylamine conjugates as capturing agents for biologically active molecules, such as antigens. The patent outlines methods for stimulating or enhancing an immune response to protect against HBV infection. A preferred conjugate mentioned in the patent is N-palmitoyl D-erythro sphingosyl-1-carbamoyl spermine (CCS).

Career Highlights

Throughout her career, Sarit has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Bio-Lab, Inc. Her experience in these companies has contributed to her expertise in vaccine development and immunology.

Collaborations

Sarit has collaborated with notable colleagues, including Yechezkel Bareholz and Eliezer Kedar. These partnerships have furthered her research and innovation in the field of vaccine development.

Conclusion

Sarit Samira is a pioneering inventor whose work in Hepatitis B virus vaccination showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact public health and improve vaccine efficacy.